V350A & V350BA Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).

Sponsor:

Merck Sharp & Dohme LLC

Code:

NCT06655324

Conditions

Healthy

Eligibility Criteria

Sex: All

Age: 12 - 30

Healthy Volunteers: Accepted

Interventions

V350A

V350B

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-21. This information was provided to ClinicalTrials.gov by Merck Sharp & Dohme LLC on 2026-07-24.